
Pixyl
Neuroimaging AI for Improved Patient Care.
- B2B
- saas
- commission
- health
- health platform
- medical devices
- biotechnology
- machine learning
- deep tech
- artificial intelligence
- dt and ls
- biotechnology
- horizon europe
- core ai
- radar de l'innovation
- analytics
- ai applications
- tech for business
- eit ecosystem
- ai agents
- observatoire deeptech
- neurology
- drug development
- eit health
- health it
- patient care
- biotech, medtech and e-health
- physician support tools
- hospital
- medical imaging
- clinical decision support
- ai for medical imaging
- precision medicine
- radiology
- health information
- bridgehead europe (eit health)
- bridgehead europe 2020 (eit health)
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
* | N/A | Acquisition | |
Total Funding | 000k |







EUR | 2019 | 2020 | 2021 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Pixyl is a company that specializes in the application of artificial intelligence to medical imaging, with a particular focus on neurology. Founded in 2015 by a team of researchers and entrepreneurs, the company has developed a suite of AI-powered software solutions designed to assist clinicians in the analysis of brain MRI scans.
The company's flagship product, Pixyl.Neuro, is a software platform that uses deep learning algorithms to automatically detect and quantify biomarkers associated with a range of neurological disorders, including multiple sclerosis, Alzheimer's disease, and traumatic brain injury. By providing a more objective and efficient means of analyzing MRI data, Pixyl aims to improve the accuracy and speed of diagnosis, as well as facilitate the monitoring of disease progression and treatment response.
The business model of Pixyl is centered on providing its software as a service (SaaS) to healthcare providers, including hospitals, imaging centers, and research institutions. The company's solutions are designed to integrate seamlessly with existing clinical workflows, offering a user-friendly interface and compatibility with a wide range of MRI scanners and imaging protocols. Pixyl's revenue is generated through subscription fees, which are typically based on the volume of scans processed or the number of users.
Keywords: AI, medical imaging, neurology, MRI analysis, deep learning, biomarkers, multiple sclerosis, Alzheimer's disease, SaaS, healthcare technology